MLN-8054

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameMLN-8054
Drug Alias NameMLN-8054
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Aurora-A inhibitors
TargetsSerine/threonine-protein kinase Aurora-A
Therapy Area/IndicationsUrinary Bladder NeoplasmsPancreatic NeoplasmsColonic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMillennium Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsPancreatic NeoplasmsColonic Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A